Population pharmacokinetic modeling of Sepantronium bromide (YM155), a small molecule survivin suppressant, in patients with non-small cell lung cancer, hormone refractory prostate cancer, or unresectable stage III or IV melanoma

Purpose Population pharmacokinetics (PK) of sepantronium bromide (YM155) was characterized in patients with non-small cell lung cancer, hormone refractory prostate cancer, or unresectable stage III or IV melanoma and enrolled in one of three phase 2 studies conducted in Europe or the U.S. Method Sep...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Aoyama, Yumiko, Kaibara, Atsunori, Takada, Akitsugu, Nishimura, Tetsuya, Katashima, Masataka, Sawamoto, Taiji
Format: Artigo
Jezik:Inglês
Izdano: Springer US 2012
Teme:
Phase II Studies
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3589632/
https://ncbi.nlm.nih.gov/pubmed/22892872
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10637-012-9867-x
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki